AHF proposes innovative solution to resolve AIDS drug crisis in Florida

As the State of Florida grapples with a budget shortfall that is crippling its AIDS Drug Assistance Program and forcing the state to place more than 1,300 low-income Floridians on waiting lists to access lifesaving AIDS medications, AIDS Healthcare Foundation has proposed an innovative solution to state health officials and seven leading AIDS drug companies [...]

Research marks new direction to treat Pneumocystis, inflammatory diseases

A drug to treat inflammation plays a surprising role reducing the level of infection caused by an opportunistic bug that is deadly for AIDS and cancer patients and others with weakened immune systems.

Bristol-Myers Squibb And ADAP Crisis Task Force Announce Enhanced, Multi-year Support For AIDS Drug Assistance Programs (ADAPs) In The United States

Bristol-Myers Squibb Company (NYSE: BMY) and the ADAP Crisis Task Force (ACTF) announced an enhanced agreement to support the efforts of AIDS Drug Assistance Programs (ADAPs) to provide antiretroviral medicines to people living with HIV and AIDS…

Also In Global Health News: AIDS Vaccine Testing; Misoprostol In Pakistan; Russian Wheat Exports; Generic Drugs In Uganda; Poverty In Egypt; More

Crucell And Harvard To Test Experimental AIDS Vaccine In Uninfected Adults The pharmaceutical company Crucell, in collaboration with Harvard University, “plans to test its experimental AIDS vaccine in the U.S. and in Africa, advancing the quest for a protective shot against” HIV, Bloomberg reports…

Bristol-Myers Squibb, ACTF announce enhanced agreement to support ADAPs

Bristol-Myers Squibb Company and the ADAP Crisis Task Force today announced an enhanced agreement to support the efforts of AIDS Drug Assistance Programs to provide antiretroviral medicines to people living with HIV and AIDS. Building on an agreement signed in March of 2010, today’s announcement marks a multi-year enhancement to assist ADAPs in meeting the [...]

Bloomberg BusinessWeek Explores Growing Trend In Pharma To License, Donate HIV Drugs

“Pharmaceutical companies, once blasted as uncaring or downright greedy for charging thousands of dollars for a year’s worth of AIDS medicines …

BMS to join ranks of AIDS drug companies to offer price concessions

Bristol-Myers Squibb (BMS) will soon announce an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide. The agreement, with the ADAP Crisis Task Force (ACTF) of the National Alliance of State & Territorial AIDS Directors (NASTAD), is expected to be announced any day. BMS has been the target of a sustained advocacy campaign [...]

Bloomberg Businessweek explores growing trend in pharma to license, donate HIV drugs

“Pharmaceutical companies, once blasted as uncaring or downright greedy for charging thousands of dollars for a year’s worth of AIDS medicines … in poor countries, lately have been slashing prices and licensing their drugs for free or nominal cost to nonprofits or local manufacturers in the developing world,” Bloomberg BusinessWeek writes in an analysis piece [...]

Also In Global Health News: Meningitis Vaccine; Women And HIV/AIDS Response; Rain Hits West Africa; AIDS 2010

New Meningitis Vaccine Scheduled For ‘Mass Campaign’ In October The WHO “recently gave approval to a new meningitis vaccine that is expected to cost only 50 cents a dose, a price many African governments and donors can afford,” the New York Times reports…

Opinions: IDUs And HIV; AIDS 2010; International Violence Against Women Act

Governments Should Examine Drug Policies To Slow HIV Transmission Among IDUs In a Los Angeles Times opinion piece, Evan Wood, associate professor of medicine at the University of British Columbia, writes about the Vienna Declaration, a document he helped to draft, that calls for international leaders to revise drug policies [...]